Advertisement
Advertisement
XTNT
Xtant Medical Holdings, Inc.
0.50
USDSponsored
-0.04
-6.78%
Apr 02, 15:58 UTC -4
Closed
After-Market
0.49
0.00
-0.20%
XTNT Earnings Reports
Positive Surprise Ratio
XTNT beat 14 of 29 last estimates.
48%
Next Report
Date of Next Report
Apr 30, 2026
Estimate for Q1 26 (Revenue/ EPS)
$22.44M
/-$0.01
Implied change from Q4 25 (Revenue/ EPS)
-19.02%
/--
Implied change from Q1 25 (Revenue/ EPS)
-31.80%
/--
Xtant Medical Holdings, Inc. earnings per share and revenue
On Mar 31, 2026, XTNT reported earnings of 0.00 USD per share (EPS) for Q4 25, beating the estimate of 0.00 USD, resulting in a 100.00% surprise. Revenue reached 27.71 million, compared to an expected 31.36 million, with a -11.65% difference. The market reacted with a -0.13% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 22.44 million USD, implying an -- of --% EPS, and decrease of -19.02% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
Microbot Medical, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+34.64%
Lucid Diagnostics Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.10
Surprise
+1.96%
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
Atossa Therapeutics, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.16
Actual
-$3.08
Surprise
-165.45%
Adagio Medical Holdings, Inc Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$0.31
Actual
-$0.16
Surprise
+49.40%
PAVmed Inc. Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$5.50
Actual
-$5.52
Surprise
-0.22%
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
FAQ
What were Xtant Medical Holdings, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Xtant Medical Holdings, Inc. reported EPS of $0.00, beating estimates by 100%, and revenue of $27.71M, -11.65% below expectations.
How did the market react to Xtant Medical Holdings, Inc.'s Q4 2025 earnings?
The stock price moved down -0.13%, changed from $0.63 before the earnings release to $0.63 the day after.
When is Xtant Medical Holdings, Inc. expected to report next?
The next earning report is scheduled for Apr 30, 2026.
What are the forecasts for Xtant Medical Holdings, Inc.'s next earnings report?
Based on 4
analysts, Xtant Medical Holdings, Inc. is expected to report EPS of -$0.01 and revenue of $22.44M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement